Author Affiliations: Division of Research in Women's Health, Department of Obstetrics, Gynecology and Community Health, Women and Infants' Hospital, Brown University School of Medicine, Providence, RI.
Contempo Updates Section Editors: Thomas
C. Jefferson, MD, Contributing Editor; Stephen J. Lurie, MD, PhD, Contributing
In ambulatory gynecology and the primary care of women, there are few
preventive services that pass a careful evidence-based assessment of effectiveness.
A relatively small percentage (<15%) of the screening and counseling interventions
evaluated by the US Preventive Services Task Force received an "A" recommendation.1 The Papanicolaou test is one example of an "A" recommendation
from the task force as an effective preventive service in women's health.
Chemoprophylaxis, the use of chemicals or medications to prevent the occurrence
of a disease, is another strategy for prevention. An excellent example of
effective chemoprophylaxis in women's health is the use of emergency contraception
to prevent unintended pregnancy. Recent advances in emergency contraception
and Papanicolaou test technology have changed the practice patterns in many
clinical centers. This update of ambulatory gynecology will provide an assessment
of the state-of-the-science for these 2 areas and will also describe some
recent provocative research concerning bacterial vaginosis.
Peipert JF. Ambulatory Gynecology. JAMA. 2000;283(20):2630–2632. doi:10.1001/jama.283.20.2630
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: